Sekar Durairaj, Venugopal Basam, Sekar Punitha, Ramalingam Krishnan
Stem Cell Division, Cryovault Biotech Pvt Ltd, Bangalore 560016, India.
Stem Cell Division, Cryovault Biotech Pvt Ltd, Bangalore 560016, India.
Gene. 2016 May 10;582(1):14-8. doi: 10.1016/j.gene.2016.01.039. Epub 2016 Jan 27.
Diabetes mellitus (DM) is a disease related to metabolic disorder and becoming an epidemic in developing countries. Current treatments for DM include modified lifestyle practice, obesity treatment, oral hypoglycemic agents, and insulin sensitizers, yet no cure is available in sight for the disease, despite it requires new insight into the molecular and pathophysiology. MicroRNAs (miRNAs) are small noncoding RNAs considered as of greater biological importance and controls molecular signaling pathways in diabetic pathogenesis. The microRNA 21 is an important microRNA frequently upregulated in all types of diseases suggesting that it plays an important role in cell proliferation, and apoptosis. The present mini review highlights the recent investigations related to the importance of miR-21 in different types of DM based on the up-to-date reports.
糖尿病(DM)是一种与代谢紊乱相关的疾病,在发展中国家正呈流行趋势。目前糖尿病的治疗方法包括改变生活方式、治疗肥胖、口服降糖药和胰岛素增敏剂,然而尽管该疾病需要对分子和病理生理学有新的见解,但目前仍没有治愈方法。微小RNA(miRNA)是一类小的非编码RNA,被认为具有更重要的生物学意义,并在糖尿病发病机制中控制分子信号通路。微小RNA 21是一种重要的微小RNA,在所有类型的疾病中经常上调,这表明它在细胞增殖和凋亡中起重要作用。本综述基于最新报告,重点介绍了与miR-21在不同类型糖尿病中的重要性相关的最新研究。